This study evaluates the efficacy of behavioral therapy, including Cognitive Behavioral Therapy (CBT), relaxation techniques, and biofeedback, in managing Temporomandibular Disorders (TMD). It aims to address both the physical and psychological aspects of TMD, focusing on pain reduction, improved jaw function, and alleviating psychological distress such as anxiety and depression. Participants are randomized into two groups: an intervention group receiving behavioral therapy and a control group receiving standard care. Outcomes will be assessed using validated tools to measure pain intensity, jaw function, and psychological well-being at baseline, post-treatment, and at a 6-month follow-up. This research seeks to establish the role of behavioral therapy as a key component in the comprehensive management of TMD.

Inclusion Criteria:

• Adults aged 18-65 years.
• Diagnosed with Temporomandibular Disorders (TMD) based on DC/TMD Axis I and Axis II criteria.
• Presenting with symptoms such as jaw pain, limited jaw movement, or psychosocial distress (anxiety, depression).
• Willing and able to provide informed consent.
• Able to comply with the study protocol and attend all follow-up visits.

Exclusion Criteria:

• Severe systemic diseases or other neurological conditions that could interfere with treatment or outcomes.
• History of psychiatric disorders unrelated to TMD, such as schizophrenia or bipolar d disorder.
• Pregnant or lactating women.
• Use of medications or treatments within the past month that could influence study outcomes (e.g., corticosteroids, strong analgesics).
• Individuals with severe dental or maxillofacial conditions requiring immediate surgical intervention.
• Non-compliance with previous medical advice or treatment for TMD. Participants unable to understand or follow the study procedures due to language barriers or cognitive impairments.

Individual Participant Data (IPD) from this study will not be shared with other researchers. This decision is based on the need to protect participant privacy and confidentiality, as well as the sensitive nature of the data collected, including psychological and health-related information. Although the study results will be shared in aggregated and anonymized formats through publications and presentations, no raw or identifiable participant data will be disclosed to external parties. This approach ensures compliance with ethical guidelines and data protection regulations.